EE+ POEM Archive
GLP-1 agonists are associated with a lower risk of obesity-related cancer than other glucose-lowering drugs
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "GLP-1 Agonists Are Associated With a Lower Risk of Obesity-related Cancer Than Other Glucose-lowering Drugs." EE+ POEM Archive, John Wiley & Sons, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377541/all/GLP_1_agonists_are_associated_with_a_lower_risk_of_obesity_related_cancer_than_other_glucose_lowering_drugs.
GLP-1 agonists are associated with a lower risk of obesity-related cancer than other glucose-lowering drugs. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2026. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377541/all/GLP_1_agonists_are_associated_with_a_lower_risk_of_obesity_related_cancer_than_other_glucose_lowering_drugs. Accessed January 24, 2026.
GLP-1 agonists are associated with a lower risk of obesity-related cancer than other glucose-lowering drugs. (2026). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377541/all/GLP_1_agonists_are_associated_with_a_lower_risk_of_obesity_related_cancer_than_other_glucose_lowering_drugs
GLP-1 Agonists Are Associated With a Lower Risk of Obesity-related Cancer Than Other Glucose-lowering Drugs [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2026. [cited 2026 January 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377541/all/GLP_1_agonists_are_associated_with_a_lower_risk_of_obesity_related_cancer_than_other_glucose_lowering_drugs.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - GLP-1 agonists are associated with a lower risk of obesity-related cancer than other glucose-lowering drugs
ID - 3377541
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377541/all/GLP_1_agonists_are_associated_with_a_lower_risk_of_obesity_related_cancer_than_other_glucose_lowering_drugs
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
